From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

MediVector Receives $135.5M DTRA Award

by Stephanie Lizotte
March 13, 2012
Biological and Chemical Defense Notable Contracts

MediVector, Inc., a privately held drug development company in Boston, is being awarded a $138,500,000 contract under a DoD Joint Project Manager Transformation Medical Technologies (JPM-TMT) initiative for advanced development of emerging infectious diseases medical countermeasures for FDA licensure.

Specifically, the company will further develop Favipiravir (T-705), a broad-spectrum therapeutic against multiple influenza viruses, including pandemic and drug resistant strains.

“Currently available medical countermeasures do not adequately protect the Joint Force,” said David E. Hough, Joint Project Manager of JPM-TMT.  “This drug shows promise that it can mitigate flu symptoms by interfering with the influenza replication process.  Our contract with MediVector addresses a capability gap in the protection of the Joint Forces.”

The Defense Threat Reduction Agency, Fort Belvoir, Va., is the contracting activity (HDTRA1-12-C-0031). The solicitation was issued for full and open competition and four proposals were received. Work is expected to be completed April 2016.

From Our Partners
Tags: AntiviralsAwardsDefense Threat Reduction AgencyInfluenzaJPEO-CBRNDPandemic

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC